Skyline Competitors

Summary

Skyline Medical competes with Transocean, Cumberland Pharmaceuticals, BioNTech, Teleflex Incorporated, and Noble Plc; as well as few others. The company conducts business under null sector and is part of null industry. Analyzing Skyline Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Skyline Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Skyline Medical competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
0.00	0.00	0.00

Details

Intrinsic

Valuation

Low	Real	High
0.00	0.00	0.00

Details

Skyline Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Skyline Medical and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Skyline and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Skyline Medical does not affect the price movement of the other competitor.

	RIG	CPIX	BNTX	TFX	NE	AWLCF	RDNT
RIG		-0.01	0.08	-0.12	0.67	0.0	0.16	RIG
CPIX	-0.01		-0.09	0.6	0.27	0.43	-0.47	CPIX
BNTX	0.08	-0.09		0.01	0.09	0.01	0.18	BNTX
TFX	-0.12	0.6	0.01		0.27	0.76	-0.82	TFX
NE	0.67	0.27	0.09	0.27		0.12	0.0	NE
AWLCF	0.0	0.43	0.01	0.76	0.12		-0.81	AWLCF
RDNT	0.16	-0.47	0.18	-0.82	0.0	-0.81		RDNT
	RIG	CPIX	BNTX	TFX	NE	AWLCF	RDNT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

AWLCF	+ 0.76	TFX
NE	+ 0.67	RIG
TFX	+ 0.6	CPIX
AWLCF	+ 0.43	CPIX
NE	+ 0.27	CPIX
NE	+ 0.27	TFX

High negative correlations

RDNT	- 0.82	TFX
RDNT	- 0.81	AWLCF
RDNT	- 0.47	CPIX
TFX	- 0.12	RIG
BNTX	- 0.09	CPIX
CPIX	- 0.01	RIG

Risk-Adjusted Indicators

There is a big difference between Skyline Stock performing well and Skyline Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Skyline Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RIG	2.54	(0.22)	0.00	(0.07)	0.00	0.00	5.19	(5.66)	14.43
CPIX	2.27	(0.06)	(0.04)	(0.02)	2.64	(3.00)	4.65	(5.00)	21.23
BNTX	2.38	0.37	0.14	0.45	2.30	(2.77)	5.96	(3.90)	24.81
TFX	1.19	(0.41)	0.00	(0.41)	0.00	0.00	1.71	(1.92)	17.00
NE	1.85	(0.31)	0.00	(0.08)	0.00	0.00	3.36	(3.50)	14.34
AWLCF	0.08	(0.05)	0.00	(44.05)	0.00	0.00	0.00	0.00	2.54
RDNT	1.98	0.25	0.14	0.29	1.82	(2.19)	3.77	(2.61)	22.33

Unable to evaluate fundamental data of [RIG, CPIX, BNTX, TFX, NE, AWLCF, RDNT] at this time. Please try again later

All Fundamental Data

Skyline Medical Competitive Analysis

The better you understand Skyline Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Skyline Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Skyline Medical's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	RIG	CPIX	BNTX	TFX	NE	AWLCF	RDNT
	0.91 4.36 Transocean	7.14 1.30 Cumberland	1.01 117.20 BioNTech	0.76 194.31 Teleflex	1.20 33.87 Noble	0.00 1.92 Awilco	1.33 82.85 RadNet
Market Volatility (90 Days Market Risk)	Slightly risky	Risky	Very steady	Very steady	Very steady	Not too volatile	Very steady
Market Performance (90 Days Performance)	Insignificant	Weak	OK	Very Weak	Very Weak	Very Weak	Good
Odds of Financial Distress (Probability Of Bankruptcy)	About Average	Below Average	Very Low	Very Low	Very Low	Low	Low
Current Valuation (Equity Enterprise Value)	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued	Fairly Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Buy	Strong Buy	Strong Buy	Buy	Strong Buy	Not Available	Strong Buy
Trade Advice (90 Days Macroaxis Advice)	Strong Buy	Strong Hold	Strong Hold	Strong Buy	Strong Hold	Strong Hold	Strong Buy
Current Ratio	1.64 X	1.80 X	5.15 X	2.39 X	1.94 X	0.92 X	0.79 X
Net Asset	20.25 B	81.78 M	23.01 B	7.53 B	5.51 B	26.23 M	2.69 B
Profit Margin	(0.19) %	(0.30) %	(0.15) %	0.08 %	0.19 %	N/A	(0) %
EBITDA	501 M	153.32 K	1.09 B	743.74 M	872.73 M	(55.28 M)	292.79 M
Operating Margin	0.16 %	(0.19) %	0.02 %	0.20 %	0.24 %	(3.36) %	0.08 %
Current Valuation	10.38 B	23.67 M	10.74 B	10.64 B	6.96 B	(1.95 M)	7.04 B
Price To Book	0.38 X	0.79 X	1.39 X	2.01 X	1.15 X	0.27 X	6.76 X
Retained Earnings	(4.03 B)	(17.49 M)	19.76 B	4.11 B	541.16 M	107 M	(79.58 M)
Current Asset	4.79 B	66.96 M	284.67 M	1 B	1.24 B	136 M	229.37 M
Five Year Return	N/A	N/A	N/A	0.44 %	5.21 %	29.95 %	N/A
Beta	2.79	0.22	0.26	1.18	1.0	1.61	1.75
Number Of Employees	5.43 K	91	6.13 K	14.5 K	3.6 K	12	10 K
Shares Outstanding	875.8 M	14.04 M	239.74 M	46.44 M	160.37 M	545.82 K	74.03 M
Cash Flow From Operations	164 M	6.09 M	5.37 B	510.64 M	574.34 M	(2.35 M)	220.86 M
Annual Yield	N/A	N/A	N/A	0.01 %	0.06 %	N/A	N/A
Total Debt	7.85 B	18.43 M	219.1 M	1.93 B	611.87 M	N/A	1.49 B
Return On Equity	-0.0606	-0.36	-0.024	0.0541	0.12	-2.04	0.032
Z Score	N/A	N/A	N/A	N/A	N/A	3.6	N/A
Return On Asset	0.0061	-0.0564	-0.0124	0.0315	0.0596	-0.36	0.0239
Number Of Shares Shorted	147.49 M	89.61 K	2.47 M	675.04 K	11.51 M	N/A	3.48 M
Book Value Per Share	11.68 X	1.77 X	79.73 X	96.50 X	29.22 X	(1.41) X	12.10 X
Current Liabilities	2.67 B	11.69 M	143.37 M	664.12 M	863.58 M	49 M	156.96 M
Total Asset	20.25 B	81.78 M	23.01 B	7.53 B	5.51 B	26.23 M	2.69 B
Debt To Equity	0.64 %	0.50 %	0.01 %	0.46 %	0.14 %	29.20 %	3.20 %
Short Ratio	7.44 X	1.20 X	2.64 X	1.44 X	4.87 X	N/A	6.12 X
Target Price	5.33	8.5	129.46	245.01	45.4	N/A	89.17
Last Dividend Paid	N/A	N/A	N/A	1.36	1.7	N/A	N/A
Shares Owned By Institutions	71.41 %	14.68 %	20.64 %	99.78 %	78.87 %	3.30 %	87.15 %
Market Capitalization	3.82 B	18.25 M	28.1 B	9.02 B	5.37 B	58.95 K	6.13 B
Price To Earning	(3.44) X	(16.05) X	5.19 X	38.28 X	29.72 X	18.64 X	55.56 X
Price To Earnings To Growth	(22.91) X	N/A	0.04 X	0.99 X	0.01 X	N/A	2.32 X
Price To Sales	1.15 X	0.50 X	9.24 X	2.98 X	2.03 X	0.80 X	3.46 X
Net Income	(954 M)	(6.28 M)	1.19 B	356.33 M	481.9 M	(72.23 M)	3.04 M
Earnings Per Share	(0.76) X	(0.76) X	(2.05) X	5.03 X	3.40 X	(1.16) X	(0.07) X
Shares Owned By Insiders	16.68 %	44.72 %	61.65 %	0.28 %	20.63 %	4.59 %	10.62 %
Revenue	2.83 B	39.55 M	3.82 B	2.97 B	2.59 B	33.08 M	1.62 B
Working Capital	729 M	7.73 M	17.46 B	800.66 M	420.07 M	87 M	141.82 M
Cash And Equivalents	683 M	18.22 M	9.33 B	292.03 M	194.14 M	10.47 M	99.17 M
Cash Per Share	1.32 X	1.24 X	38.30 X	9.08 X	2.39 X	0.19 X	1.73 X
Gross Profit	907 M	32.89 M	16.07 B	1.55 B	435.75 M	(909 K)	288.77 M
Day Typical Price	4.38	1.32	117.81	193.09	33.7	1.92	82.96
Accumulation Distribution	0.0292	0.0791	0.0257	0.0254	0.0287	N/A	0.025
Market Facilitation Index	0.13	0.11	3.07	4.95	0.98	N/A	2.1
Daily Balance Of Power	(0.31)	(0.91)	(0.39)	0.2949	0.4082	0.0	0.519
Period Momentum Indicator	(0.04)	(0.10)	(1.19)	1.46	0.4	N/A	1.09
Rate Of Daily Change	0.99	0.93	0.99	1.01	1.01	1.0	1.01
Day Median Price	4.39	1.34	118.12	192.48	33.61	1.92	83.01
Price Action Indicator	(0.04)	(0.09)	(1.51)	2.57	0.46	N/A	0.38
Coefficient Of Variation	(4,631)	577826.4	730.42	(697.21)	(2,161)	(812.40)	760.64
Mean Deviation	2.54	2.27	2.38	1.19	1.85	0.0757	1.98
Jensen Alpha	(0.22)	(0.06)	0.3696	(0.41)	(0.31)	(0.05)	0.2514
Total Risk Alpha	(0.58)	(0.59)	(0.06)	(0.65)	(0.51)	(0.1)	(0.07)
Sortino Ratio	N/A	(0.04)	0.143	N/A	N/A	N/A	0.1385
Downside Variance	N/A	9.65	7.15	N/A	N/A	N/A	4.67
Standard Deviation	3.33	3.88	3.7	2.19	2.53	0.3124	3.22
Kurtosis	0.4784	19.94	7.05	27.71	5.18	66.0	17.0
Potential Upside	5.19	4.65	5.96	1.71	3.36	N/A	3.77
Treynor Ratio	(0.07)	(0.02)	0.4469	(0.41)	(0.08)	(44.05)	0.2914
Maximum Drawdown	14.43	21.23	24.81	17.0	14.34	2.54	22.33
Variance	11.1	15.06	13.69	4.78	6.4	0.0976	10.38
Market Risk Adjusted Performance	(0.06)	(0.01)	0.4569	(0.40)	(0.07)	(44.04)	0.3014
Risk Adjusted Performance	(0.01)	0.0082	0.1125	(0.10)	(0.03)	(0.11)	0.1081
Skewness	0.1366	3.28	1.82	(4.09)	1.22	(8.12)	3.11
Semi Deviation	N/A	2.64	2.3	N/A	N/A	N/A	1.82
Information Ratio	(0.06)	(0.03)	0.1033	(0.20)	(0.1)	(0.52)	0.0929
Value At Risk	(5.66)	(5.00)	(3.90)	(1.92)	(3.50)	N/A	(2.61)
Expected Short fall	N/A	(3.00)	(2.77)	N/A	N/A	N/A	(2.19)
Downside Deviation	N/A	3.11	2.67	N/A	N/A	N/A	2.16
Semi Variance	N/A	6.99	5.29	N/A	N/A	N/A	3.31

Skyline Medical Competition Performance Charts

Five steps to successful analysis of Skyline Medical Competition

Skyline Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Skyline Medical in relation to its competition. Skyline Medical's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Skyline Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Skyline Medical's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Skyline Medical, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Skyline Medical position

In addition to having Skyline Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Shipbuilding Railroad Equipment Thematic Idea Now

Shipbuilding Railroad Equipment

Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipbuilding Railroad Equipment theme has 16 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipbuilding Railroad Equipment Theme or any other thematic opportunities.

View All Next

Launch

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Consideration for investing in Skyline Stock

If you are still planning to invest in Skyline Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Skyline Medical's history and understand the potential risks before investing.

	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC